Novartis: Multiple Sclerosis trials

The registry lists 107 Multiple Sclerosis studies with Novartis as lead sponsor. 9 are open to participants now and 46 have results posted.

Phase 1 3Phase 2 15Phase 3 24Phase 4 26No phase 42(a study in two phases counts in both)

Studies

Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying TherapiesCompletedNCT01442194
• Fingolimod -Response According to Coping - EvaluationCompletedNCT01420055Phase 4
• Biomarker Study After Initiation of Treatment With Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple SclerosisCompletedNCT01310166Phase 4
• The Gilenya Pregnancy RegistryCompletedNCT01285479
• Long Term Study of Fingolimod in MS Patients From the FTY Clinical ProgramCompletedNCT01281657
• Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) PatientsCompletedNCT01127750Phase 3
• A Study of the Effect of FTY720 on Pulmonary Function in Patients With Moderate AsthmaCompletedNCT00785083Phase 2